ATE173258T1 - Kondensierte pyridin derivate als hemmer von effekten freier radikaler - Google Patents

Kondensierte pyridin derivate als hemmer von effekten freier radikaler

Info

Publication number
ATE173258T1
ATE173258T1 AT93402095T AT93402095T ATE173258T1 AT E173258 T1 ATE173258 T1 AT E173258T1 AT 93402095 T AT93402095 T AT 93402095T AT 93402095 T AT93402095 T AT 93402095T AT E173258 T1 ATE173258 T1 AT E173258T1
Authority
AT
Austria
Prior art keywords
alkyl
nz1z2
alkoxy
phenyl
inhibiters
Prior art date
Application number
AT93402095T
Other languages
English (en)
Inventor
Andre Bachy
Laurent Fraisse
Peter Keane
Etienne Mendes
Jean-Claude Vernieres
Jacques Simiand
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Application granted granted Critical
Publication of ATE173258T1 publication Critical patent/ATE173258T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyrrole Compounds (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Toys (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
AT93402095T 1992-08-27 1993-08-25 Kondensierte pyridin derivate als hemmer von effekten freier radikaler ATE173258T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9210329A FR2695126B1 (fr) 1992-08-27 1992-08-27 Dérivés d'acide thiényl ou pyrrolyl carboxyliques, leur préparation et médicaments les contenant.

Publications (1)

Publication Number Publication Date
ATE173258T1 true ATE173258T1 (de) 1998-11-15

Family

ID=9433050

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93402095T ATE173258T1 (de) 1992-08-27 1993-08-25 Kondensierte pyridin derivate als hemmer von effekten freier radikaler

Country Status (17)

Country Link
US (2) US5360799A (de)
EP (1) EP0587473B1 (de)
JP (1) JPH06184145A (de)
KR (1) KR100267802B1 (de)
AT (1) ATE173258T1 (de)
AU (1) AU659027B2 (de)
CA (1) CA2104883A1 (de)
DE (1) DE69322033T2 (de)
DK (1) DK0587473T3 (de)
ES (1) ES2125315T3 (de)
FI (1) FI103889B (de)
FR (1) FR2695126B1 (de)
GR (1) GR3029283T3 (de)
HU (1) HU217623B (de)
MX (1) MX9305181A (de)
NO (1) NO300845B1 (de)
NZ (1) NZ248498A (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003256650A1 (en) * 2002-07-19 2004-02-09 Pharmacia Corporation Substituted thiophene carboxamide compounds for the treatment of inflammation
GB0522715D0 (en) 2005-11-08 2005-12-14 Helperby Therapeutics Ltd New use
HUE028588T2 (hu) 2005-12-13 2016-12-28 Incyte Holdings Corp Heteroaril-szubsztituált pirrolo[2,3-b]piridinek és pirrolo[2,3-b]pirimidinek mint Janus-kináz inhibitorok
EP2481735A1 (de) * 2007-05-09 2012-08-01 Pfizer Inc. Substituierte heterocyclische Derivate und Zusammensetzungen und ihre pharmazeutische Verwendung als antibakterielle Mittel
KR20100036306A (ko) * 2007-06-08 2010-04-07 헬리콘 테라퓨틱스 인코퍼레이티드 치료용 피라졸로나프티리딘 유도체
ES2423932T3 (es) 2007-08-27 2013-09-25 Basf Se Compuestos de pirazol para controlar plagas de invertebrados
CN102015705B (zh) * 2008-02-26 2013-11-13 武田药品工业株式会社 稠合的杂环衍生物及其用途
TWI607996B (zh) 2008-09-24 2017-12-11 巴地斯顏料化工廠 控制無脊椎害蟲之吡唑化合物
BRPI1012108B8 (pt) 2009-05-22 2021-05-25 Incyte Corp composto 3-[4-(7h-pirrolo[2,3-d]pirimidin-4-il)-1h-pirazol-1-il]octa no- ou heptano-nitrila, sua composição, seus usos e processo para preparar um sal de ácido fosfórico
NZ596479A (en) 2009-05-22 2014-01-31 Incyte Corp N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
ES2472918T3 (es) 2009-07-06 2014-07-03 Basf Se Compuestos de piridazina para controlar plagas de invertebrados
JP2013500246A (ja) 2009-07-24 2013-01-07 ビーエーエスエフ ソシエタス・ヨーロピア 無脊椎動物系害虫防除用ピリジン誘導体化合物
TW201113285A (en) 2009-09-01 2011-04-16 Incyte Corp Heterocyclic derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
CA2792508C (en) 2010-03-10 2018-01-16 Incyte Corporation Piperidin-4-yl azetidine derivatives as jak1 inhibitors
CA2818542A1 (en) 2010-11-19 2012-05-24 Incyte Corporation Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as jak inhibitors
US8691807B2 (en) 2011-06-20 2014-04-08 Incyte Corporation Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as JAK inhibitors
TW201313721A (zh) 2011-08-18 2013-04-01 Incyte Corp 作為jak抑制劑之環己基氮雜環丁烷衍生物
UA111854C2 (uk) 2011-09-07 2016-06-24 Інсайт Холдінгс Корпорейшн Способи і проміжні сполуки для отримання інгібіторів jak
TW201406761A (zh) 2012-05-18 2014-02-16 Incyte Corp 做爲jak抑制劑之哌啶基環丁基取代之吡咯并吡啶及吡咯并嘧啶衍生物
CA2888816A1 (en) 2012-11-01 2014-05-08 Incyte Corporation Tricyclic fused thiophene derivatives as jak inhibitors
KR102242077B1 (ko) 2012-11-15 2021-04-20 인사이트 홀딩스 코포레이션 룩솔리티니브의 서방성 제형
EP3489239B1 (de) 2013-03-06 2021-09-15 Incyte Holdings Corporation Verfahren und zwischenprodukte zur herstellung eines jak-hemmers
MX376856B (es) 2013-08-07 2025-03-07 Incyte Holdings Corp Formas de dosificacion de liberacion prolongada para un inhibidor de jak 1 (cinasa de janus 1).
SG11201609016VA (en) 2014-04-30 2016-11-29 Incyte Corp Processes of preparing a jak1 inhibitor and new forms thereto
WO2015184305A1 (en) 2014-05-30 2015-12-03 Incyte Corporation TREATMENT OF CHRONIC NEUTROPHILIC LEUKEMIA (CNL) AND ATYPICAL CHRONIC MYELOID LEUKEMIA (aCML) BY INHIBITORS OF JAK1
US10407423B2 (en) 2015-11-16 2019-09-10 Fundación Para La Investigación Médica Aplicada Compounds as inhibitors of DNA methyltransferases
KR20260080448A (ko) 2018-03-30 2026-06-02 인사이트 코포레이션 Jak 억제제를 사용하는 화농성 한선염의 치료
US11833155B2 (en) 2020-06-03 2023-12-05 Incyte Corporation Combination therapy for treatment of myeloproliferative neoplasms
KR20240101561A (ko) 2021-10-14 2024-07-02 인사이트 코포레이션 Kras의 저해제로서의 퀴놀린 화합물
US11897883B1 (en) 2023-09-01 2024-02-13 King Faisal University Pyrrolo[3,2-c][1,6]naphthyridine-2-carboxylic acid compounds as CK2 inhibitors
US11891377B1 (en) 2023-09-06 2024-02-06 King Faisal University Pyrrolo[3,2-c][2,7]naphthyridine-2-carboxylic acid compounds as CK2 inhibitors
US11866437B1 (en) 2023-09-15 2024-01-09 King Faisal University 1,2-dioxo-2,3-dihydro-1H-pyrrolo[2,3-c]quinoline-7-carboxylic acid compounds as CK2 inhibitors
US11952378B1 (en) 2023-12-14 2024-04-09 King Faisal University Pyrrolo[2,3-c]isoquinoline-1,2-dione compounds as CK2 inhibitors
WO2026076207A1 (en) * 2024-10-04 2026-04-09 Incyte Corporation Tricyclic heteroaryl compounds as inhibitors of tyk2 and/or jak1

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3887570A (en) * 1973-09-28 1975-06-03 Squibb & Sons Inc Derivatives of pyrazolo(3,4-b)thieno(2,3-d)pyridine-2-carboxylic acids

Also Published As

Publication number Publication date
EP0587473A1 (de) 1994-03-16
KR100267802B1 (ko) 2000-11-01
GR3029283T3 (en) 1999-05-28
EP0587473B1 (de) 1998-11-11
NO933051L (no) 1994-02-28
FI933756A0 (fi) 1993-08-26
DE69322033D1 (de) 1998-12-17
DE69322033T2 (de) 1999-06-17
AU659027B2 (en) 1995-05-04
NO933051D0 (no) 1993-08-26
FR2695126B1 (fr) 1994-11-10
ES2125315T3 (es) 1999-03-01
NZ248498A (en) 1994-09-27
DK0587473T3 (da) 1999-07-26
NO300845B1 (no) 1997-08-04
US5360799A (en) 1994-11-01
AU4474793A (en) 1994-03-03
JPH06184145A (ja) 1994-07-05
FI933756L (fi) 1994-02-28
MX9305181A (es) 1994-06-30
HU217623B (hu) 2000-03-28
HUT64957A (en) 1994-03-28
HU9302425D0 (en) 1993-11-29
US5468750A (en) 1995-11-21
FI103889B1 (fi) 1999-10-15
CA2104883A1 (fr) 1994-02-28
FI103889B (fi) 1999-10-15
FR2695126A1 (fr) 1994-03-04
KR940003958A (ko) 1994-03-14

Similar Documents

Publication Publication Date Title
DE69322033D1 (de) Kondensierte Pyridin Derivate als Hemmer von Effekten freier Radikaler
ATE345122T1 (de) Stabile emulsionszubereitungen
DK1256569T3 (da) Phenacylamin-derivater, fremstilling deraf samt skadedyrsmiddel indeholdende disse derivater
ATE178894T1 (de) Herbizide 2,6-substituierte pyridine
NO923126D0 (no) Preparat og metode for behandling av canser
DE69414019D1 (de) Bicyclische Stichstoff enthaltende Derivate als Prolyl-Endopeptidase Inhibitoren
KR930009997A (ko) 히드록시피리돈카르복스아미드, 그의 제조 방법 및 용도
KR910019994A (ko) 시클로헥센온 옥심 에테르, 이들의 제조방법, 이들의 제조를 위한 중간체 및 이들의 제초제로서의 용도
ATE124403T1 (de) Barbitursäurederivate mit insektizider wirkung.
AU603232B2 (en) Herbicidal agents
YU165791A (sh) Postupak za pripremanje derivata 8-hlorohinolona
AU557533B2 (en) Oxadithiadiaza, dioxaselenadiaza, dioxatelluradiaza, and dioxathiadiaza-2,5-pentalene derivatives
ATE80396T1 (de) Alpha-hydroxy-azolylethyloxirane und diese enthaltende fungizide.
ATE148462T1 (de) Isoxazole derivate als lichtschutzmittel
MY104164A (en) Heterocyclic compounds.
DK44779A (da) 2-chlorsulfinylazetidin-4-on-forbindelser til anvendelse som mellemprodukter ved fremstilling af 3-exomethylencephamsulfoxider
KR870000011A (ko) 디클로로퀴놀린 유도체를 기초로한 제초 조성물

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee